Exploring the cocrystal landscape of posaconazole by combining high-throughput screening experimentation with computational chemistry

dc.accessRightsAnonymous*
dc.contributor.authorGuidetti, Matteo
dc.contributor.authorHilfiker, Rolf
dc.contributor.authorKuentz, Martin
dc.contributor.authorBauer-Brandl, Annette
dc.contributor.authorBlatter, Fritz
dc.date.accessioned2023-02-13T11:14:28Z
dc.date.available2023-02-13T11:14:28Z
dc.date.issued2022-12-23
dc.description.abstractThe development of multicomponent crystal forms, such as cocrystals, represents a means to enhance the dissolution and absorption properties of poorly water-soluble drug compounds. However, the successful discovery of new pharmaceutical cocrystals remains a time- and resource-consuming process. This study proposes the use of a combined computational-experimental high-throughput approach as a tool to accelerate and improve the efficiency of cocrystal screening exemplified by posaconazole. First, we employed the COSMOquick software to preselect and rank cocrystal candidates (coformers). Second, high-throughput crystallization experiments (HTCS) were conducted on the selected coformers. The HTCS results were successfully reproduced by liquid-assisted grinding and reaction crystallization, ultimately leading to the synthesis of thirteen new posaconazole cocrystals (7 anhydrous, 5 hydrates, and 1 solvate). The posaconazole cocrystals were characterized by PXRD, 1H NMR, Fourier transform-Raman, thermogravimetry–Fourier transform infrared spectroscopy, and differential scanning calorimetry. In addition, the prediction performance of COSMOquick was compared to that of two alternative knowledge-based methods: molecular complementarity (MC) and hydrogen bond propensity (HBP). Although HBP does not perform better than random guessing for this case study, both MC and COSMOquick show good discriminatory ability, suggesting their use as a potential virtual tool to improve cocrystal screening.en_US
dc.identifier.doi10.1021/acs.cgd.2c01072
dc.identifier.issn1528-7483
dc.identifier.issn1528-7505
dc.identifier.urihttps://irf.fhnw.ch/handle/11654/34600
dc.identifier.urihttps://doi.org/10.26041/fhnw-4627
dc.issue2en_US
dc.language.isoenen_US
dc.publisherAmerican Chemical Societyen_US
dc.relation.ispartofCrystal Growth & Designen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.subjectScreening assaysen_US
dc.subjectMoleculesen_US
dc.subjectMolecular interactionsen_US
dc.subjectGranular materialsen_US
dc.subjectDrug discoveryen_US
dc.subject.ddc600 - Technik, Medizin, angewandte Wissenschaftenen_US
dc.titleExploring the cocrystal landscape of posaconazole by combining high-throughput screening experimentation with computational chemistryen_US
dc.type01A - Beitrag in wissenschaftlicher Zeitschrift
dc.volume23en_US
dspace.entity.typePublication
fhnw.InventedHereYesen_US
fhnw.IsStudentsWorknoen_US
fhnw.ReviewTypeAnonymous ex ante peer review of a complete publicationen_US
fhnw.affiliation.hochschuleHochschule für Life Sciences FHNWde_CH
fhnw.affiliation.institutInstitut für Pharma Technologyde_CH
fhnw.openAccessCategoryHybriden_US
fhnw.pagination842-852en_US
fhnw.publicationStatePublisheden_US
relation.isAuthorOfPublication68819448-8611-488b-87bc-1b1cf9a6a1b4
relation.isAuthorOfPublication.latestForDiscovery68819448-8611-488b-87bc-1b1cf9a6a1b4
Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild
Name:
acs.cgd.2c01072.pdf
Größe:
2.61 MB
Format:
Adobe Portable Document Format
Beschreibung:

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Kein Vorschaubild vorhanden
Name:
license.txt
Größe:
1.37 KB
Format:
Item-specific license agreed upon to submission
Beschreibung: